Dostinex 0.5 mg (8 Tablets)

DOSTINEX 0.5 MG (8 TABLETS) BY PFIZER

Tablets

DRUG COMPOSITION

1 tablet contains:
 - active substance: cabergoline 0.5 mg;
 - auxiliary substances:

DRUG DESCRIPTION

PHARMACEUTICAL FORM

Tablets.

PHARMACEUTICAL GROUP AND ATC CODE

Dopamine Receptor Agonist.

PHARMACOLOGICAL PROPERTIES

PROFILE

Half life: First-pass effect seen
Routes of administration: by mouth
Dosage forms: (Men): 0.25 mg/week; (Women): -
Acne: no
Water retention: no
High blood pressure: no
Hepatotoxicity: no
Aromatase: no
Decreased HPTA function (own testosterone production): none
Anabolic activity: Not a steroid
Androgenic activity: Not a steroid
Detection time:

THERAPEUTICAL INDICATIONS

DOSES AND METHOD OF ADMINISTRATION

SIDE EFFECTS

CONTRAINDICATIONS

OVERDOSE

INTERACTIONS WITH OTHER DRUGS

PRESENTATION, PACKAGING

0.5 mg tablets.
8 tablets in sachets.

STORAGE

Store in a dry place and away from light at 15-25 ° C. Keep out of the reach and sight of children.

LEGAL STATUS

It is issued with prescription.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Pfizer
India